CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $54,128,000 | +35.4% | 1,601,427 | -6.3% | 0.96% | +14.4% |
| Q1 2021 | $39,973,000 | -4.9% | 1,708,957 | +17.1% | 0.84% | +1.2% |
| Q4 2020 | $42,018,000 | +106.3% | 1,458,957 | +45.1% | 0.83% | +67.3% |
| Q3 2020 | $20,371,000 | -22.4% | 1,005,487 | +15.1% | 0.50% | -35.2% |
| Q2 2020 | $26,260,000 | -12.4% | 873,890 | -8.4% | 0.76% | -19.6% |
| Q1 2020 | $29,987,000 | +15.7% | 954,100 | +73.5% | 0.95% | +15.1% |
| Q4 2019 | $25,911,000 | +16946.7% | 550,000 | +2230.5% | 0.83% | +13683.3% |
| Q3 2019 | $152,000 | -93.3% | 23,600 | -87.1% | 0.01% | -92.6% |
| Q2 2019 | $2,255,000 | -34.3% | 183,600 | -27.5% | 0.08% | -38.6% |
| Q1 2019 | $3,434,000 | +34.7% | 253,400 | -60.1% | 0.13% | +29.4% |
| Q4 2018 | $2,550,000 | -40.4% | 635,843 | 0.0% | 0.10% | -33.3% |
| Q3 2018 | $4,279,000 | – | 635,843 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |